Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Klinge focus continues on novel antitumor/immunosuppressive compounds

July 16, 1999

Another series of apoptotic agents designed under Cell Pathways, U. of Arizona collaboration

July 16, 1999

Novel antitumor agents from Rutgers act as topoisomerase poisons

July 15, 1999

Klinge presents new compounds with both antitumor and immunosuppressive effects

July 15, 1999

Antitumor spectrum of Sch-66336 determined in human tumor cloning assay

July 14, 1999

Bristol-Myers Squibb patents new series of CDK inhibitors

July 14, 1999

Tetrionics will supply 2ME2 for EntreMed's preclinical testing program

July 14, 1999

Onconase/interferon combination exerts synergistic antitumor activity in vitro

July 14, 1999

NeXstar begins enrolling patients in U.S. phase I trial of NX-211

July 14, 1999

Selected purine analogues tested as angiogenesis inhibitors

July 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...